Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

The Role of CRISPR Screens in Advancing Genomics CRISPR gene editing, enabled by the CRISPR/Cas9 system, has revolutionized ...

WEHI has formed a partnership with the Parkinson's Research Foundation with one clear goal: to intensify the search for drug treatments to stop ...

Conversations with entrepreneurs, technologists, and researchers on emerging technologies and the importance of STEM in drug ...

AI meets molecular dynamics in Divamics’ latest breakthroughs, accelerating new therapies for complex metabolic conditions.

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

The Novo Nordisk Foundation and Denmark's state-owned credit fund said on Thursday they will invest in what they say will be ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

Learn how AI and machine learning enhance antibody discovery – from structure prediction to binding optimization – with ...

Simulations Plus dipped after Q3 2025 on guidance cuts, but core software strength and long-term growth drivers remain. Find ...